Literature DB >> 21310539

Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention.

Jessica F Magidson1, Stephanie M Gorka2, Laura MacPherson3, Derek R Hopko4, Carlos Blanco5, C W Lejuez6, Stacey B Daughters7.   

Abstract

Effective, parsimonious behavioral interventions that target reinforcement are needed for substance users with depression to improve mood as well as treatment retention. The Life Enhancement Treatment for Substance Use (LETS ACT; Daughters et al., 2008) is a behavioral activation-based approach tailored to increase levels of positive reinforcement among depressed substance users while in substance abuse treatment. The current study tested the efficacy of LETS ACT compared to a contact-time matched control condition, supportive counseling (SC), examining effects on depressed mood, substance abuse treatment retention, and behavioral activation outcomes. Fifty-eight adult substance users in residential substance abuse treatment presenting with depressive symptoms (BDI≥12) were randomly assigned to LETS ACT or SC. Assessments were administered at pre- and post-treatment and included assessment of DSM-IV psychiatric diagnoses, depression severity, treatment motivation, overall activation, environmental reward, and substance abuse treatment retention. Patients in LETS ACT had significantly higher rates of substance abuse treatment retention and significantly greater increases in activation on the Behavioral Activation for Depression Scale (BADS) compared to those in SC. Both groups had decreased depression severity at post-treatment, although the group by time interaction was not significant. This study was the first to compare LETS ACT to a contact-time matched control treatment to evaluate effects on substance abuse treatment retention and two distinct measures of behavioral activation: overall activation and environmental reward. Findings suggest preliminary support for the feasibility, tolerability, and efficacy of a brief behavioral activation-based protocol that may be particularly useful to improve substance abuse treatment retention. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21310539      PMCID: PMC3070865          DOI: 10.1016/j.addbeh.2011.01.016

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  50 in total

1.  U.S. spending for mental health and substance abuse treatment, 1991-2001.

Authors:  Tami L Mark; Rosanna M Coffey; Rita Vandivort-Warren; Hendrick J Harwood; Edward C King
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Jun       Impact factor: 6.301

2.  Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.

Authors:  Deborah S Hasin; Renee D Goodwin; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2005-10

3.  Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.

Authors:  Roger S McIntyre; Jakub Z Konarski; Deborah A Mancini; Kari A Fulton; Sagar V Parikh; Sophie Grigoriadis; Larry A Grupp; David Bakish; Marie-Josee Filteau; Chris Gorman; Charles B Nemeroff; Sidney H Kennedy
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

4.  Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Boji Huang; Deborah A Dawson; Frederick S Stinson; Deborah S Hasin; W June Ruan; Tulshi D Saha; Sharon M Smith; Risë B Goldstein; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-07       Impact factor: 4.384

5.  The effect of depression on return to drinking: a prospective study.

Authors:  S F Greenfield; R D Weiss; L R Muenz; L M Vagge; J F Kelly; L R Bello; J Michael
Journal:  Arch Gen Psychiatry       Date:  1998-03

6.  The Environmental Reward Observation Scale (EROS): development, validity, and reliability.

Authors:  Maria E A Armento; Derek R Hopko
Journal:  Behav Ther       Date:  2006-12-12

7.  Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.

Authors:  Thomas Kosten; Alison Oliveto; Alan Feingold; James Poling; Kevin Sevarino; Elinore McCance-Katz; Susan Stine; Gerardo Gonzalez; Kishor Gonsai
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory.

Authors:  M L Van Etten; S T Higgins; A J Budney; G J Badger
Journal:  Addiction       Date:  1998-11       Impact factor: 6.526

10.  Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.

Authors:  B J Rounsaville; T R Kosten; M M Weissman; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-08
View more
  32 in total

1.  Activity enjoyment, not frequency, is associated with alcohol-related problems and heavy episodic drinking.

Authors:  Jessica F Magidson; Briana L Robustelli; C J Seitz-Brown; Mark A Whisman
Journal:  Psychol Addict Behav       Date:  2016-09-15

2.  The efficacy of behavioral activation treatment among depressed Spanish-speaking Latinos.

Authors:  Anahí Collado; Marilyn Calderón; Laura MacPherson; Carl Lejuez
Journal:  J Consult Clin Psychol       Date:  2016-04-07

3.  Pilot of the brief behavioral activation treatment for depression in latinos with limited english proficiency: preliminary evaluation of efficacy and acceptability.

Authors:  Anahi Collado; Soraida D Castillo; Fabian Maero; C W Lejuez; Laura Macpherson
Journal:  Behav Ther       Date:  2013-10-16

4.  Psychosocial factors associated with treatment outcomes in women with obesity and major depressive disorder who received behavioral activation for depression.

Authors:  Daniel Kern; Andrew Busch; Kristin L Schneider; Steven A Miller; Bradley M Appelhans; Molly E Waring; Matthew C Whited; Sherry Pagoto
Journal:  J Behav Med       Date:  2018-11-22

5.  Making the hard work of recovery more attractive for those with substance use disorders.

Authors:  James R McKay
Journal:  Addiction       Date:  2016-08-17       Impact factor: 6.526

6.  Pilot of a Behavioral Activation-Enhanced Smoking Cessation Program for Substance Users With Elevated Depressive Symptoms in Residential Treatment.

Authors:  Anne N Banducci; C W Lejuez; Laura MacPherson
Journal:  Addict Newsl Am Psychol Div 50       Date:  2013

7.  Development and Preliminary Feasibility Study of a Brief Behavioral Activation Mobile Application (Behavioral Apptivation) to Be Used in Conjunction With Ongoing Therapy.

Authors:  Jennifer Dahne; Jacob Kustanowitz; C W Lejuez
Journal:  Cogn Behav Pract       Date:  2017-06-06

8.  Applying behavioral economic theory to problematic Internet use: An initial investigation.

Authors:  Samuel F Acuff; James MacKillop; James G Murphy
Journal:  Psychol Addict Behav       Date:  2018-11

9.  Theory-driven intervention for changing personality: expectancy value theory, behavioral activation, and conscientiousness.

Authors:  Jessica F Magidson; Brent W Roberts; Anahi Collado-Rodriguez; C W Lejuez
Journal:  Dev Psychol       Date:  2012-10-29

10.  Integrating Motivational Interviewing and Brief Behavioral Activation Therapy: Theoretical and Practical Considerations.

Authors:  Iván C Balán; C W Lejuez; Marcela Hoffer; Carlos Blanco
Journal:  Cogn Behav Pract       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.